Skip to content

Clinical trials

Completed Acquired Immunodeficiency Syndrome trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Not applicable Status: Completed Clear all

857 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20024
20033
200410
20057
20068
200712
200814
200914
201015
201121
201226
201333
201425
201537
201640
201760
201866
201972
202038
202151
202238
202331
202411
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed857

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)54
University of California, San Francisco41
Columbia University24
Pfizer21
University of North Carolina, Chapel Hill21
University of Washington21
Johns Hopkins University19
Massachusetts General Hospital19
University of Pennsylvania17
Emory University16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome857
HIV Infections293
AIDS-Related Opportunistic Infections72
AIDS-Related Complex69
Substance-Related Disorders44
Sexually Transmitted Diseases41
Tuberculosis28
Cytomegalovirus Infections22
Pneumonia, Pneumocystis22
Hepatitis C20

Trials

Showing 1 to 25 of 857. Each trial links to its page on Pharma Observatory.

757 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.